RAC1 and lung carcinoma: The phalloidin staining results showed that RAC1 inhibitor could significantly inhibit the expression of polymeric actin in lung cancer (P < 0.01), and RAC1 agonist agent could significantly promote the expression of polymeric actin in lung cancer cells (P < 0.05, Fig. 6e).